HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

AbstractCONTEXT:
CDKN1B encodes the cyclin-dependent kinase inhibitor p27Kip1 and is mutated in multiple endocrine neoplasia-like syndromes. CDKN1B also harbors single nucleotide polymorphisms; the T/G transversion at nucleotide 326 (the V109G variant) has been reported to be protective in breast, hereditary prostate, and pancreatic tumors. Association of CDNK1B mutations or polymorphisms with sporadic medullary thyroid carcinoma (MTC) has not been investigated yet.
OBJECTIVE AND DESIGN:
We screened germline DNA from 84 patients affected by sporadic MTC and 90 healthy age- and gender-matched controls for CDKN1B mutations or polymorphisms by PCR amplification and sequencing of the amplicons. We also tested all germline and 50 tumor tissue DNA for RET proto-oncogene mutations. Computed tomography, ultrasound scans, and serum calcitonin were carried out before surgery and during the follow-up and associated with CDKN1B polymorphism and disease remission.
RESULTS:
The T/G transversion at nucleotide 326 was the only DNA variation detected. The overall frequency of the T/G and G/G alleles in combination was 46.4%. This variant (V109G) was correlated with post-operative calcitonin levels in the normal range and biochemical remission. Conversely, the wild-type (T/T) allele was associated with post-operative calcitonin levels above normal and a higher risk to develop clinical recurrence and distant metastases. Somatic RET mutations were significantly associated with a more aggressive behavior especially in wild-type allele-bearing patients.
CONCLUSIONS:
Collectively, in sporadic MTC, the CDKN1B V109G polymorphism correlates with a more favorable disease progression than the wild-type allele and might be considered a new promising prognostic marker.
AuthorsDaniela Pasquali, Luisa Circelli, Antongiulio Faggiano, Massimo Pancione, Andrea Renzullo, Rossella Elisei, Cristina Romei, Giacomo Accardo, Viviana Raffaella Coppola, Maurizio De Palma, Piero Ferolla, Franco Grimaldi, Annamaria Colao, Vittorio Colantuoni
JournalEuropean journal of endocrinology (Eur J Endocrinol) Vol. 164 Issue 3 Pg. 397-404 (Mar 2011) ISSN: 1479-683X [Electronic] England
PMID21177330 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CDKN1B protein, human
  • Intracellular Signaling Peptides and Proteins
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Cyclin-Dependent Kinase Inhibitor p27
  • Calcitonin
Topics
  • Adult
  • Calcitonin (blood)
  • Carcinoma, Neuroendocrine
  • Cyclin-Dependent Kinase Inhibitor p27
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins (genetics)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Polymorphism, Single Nucleotide (genetics)
  • Proportional Hazards Models
  • Proto-Oncogene Mas
  • Thyroid Neoplasms (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: